Company profile
Tavira Therapeutics company profile
Tavira Therapeutics develops an advanced platform that enhances gene delivery of AAV (adeno-associated virus). The company's approach is to equip AAV vectors with specific molecules that allow for more targeted and safer gene therapies, representing a significant advancement in the field. Founded as a spin-off from KU Leuven and Trellis, Tavira is leveraging groundbreaking research to develop modular AAV capsid technologies to improve gene therapy treatments.
Business identity
- Website
- https://www.taviratx.com
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2023-01-01, Year
Headquarters
- Headquarters
- Teuven, Limburg, Belgium
- Postal code
- 3001
- Country code
- BE
- Continent
- Europe